Carvedilol ER 20 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F4F6C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,312
Award facts
- Contract value 100% obligated
- $22,312.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,312.07 to AmerSourceBergen Drug Corp for the supply of Carvedilol ER 20 mg capsules (30-count units) with a firm fixed price structure. This non-set-aside contract was competitively awarded on January 26, 2026, with an ultimate completion date of January 27, 2026, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerSourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Logistics Agency. The company's extensive portfolio includes brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains. The carvedilol delivery under this order supports DLA's ongoing pharmaceutical supply chain operations, enabling the company to fulfill essential medication requirements for military treatment facilities and other federal healthcare institutions. All of AmerSourceBergen's reviewed contract awards with DLA have been competitively awarded with firm fixed pricing, demonstrating the company's capability to meet federal procurement requirements through open competition.
Quick answers
Who was awarded contract SPE2DR26F4F6C?
SPE2DR26F4F6C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26F4F6C worth?
The government has obligated $22,312 on SPE2DR26F4F6C.
Is contract SPE2DR26F4F6C an order under another contract?
Yes. SPE2DR26F4F6C is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4F6C competed?
The extent of competition for SPE2DR26F4F6C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award